Wayne, PA, United States of America

Wesley Harton Kaupinen

USPTO Granted Patents = 6 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Wesley Harton Kaupinen: Innovator in mTOR Inhibitor Compositions**

Introduction

Wesley Harton Kaupinen is an accomplished inventor based in Wayne, PA, known for his contributions to the field of biotechnology. With a total of four patents to his name, Kaupinen has focused on developing innovative solutions for skin disorders through the use of mTOR inhibitors.

Latest Patents

Kaupinen's most recent patents include groundbreaking work on anhydrous compositions of mTOR inhibitors and methods of use. These compositions are designed for the topical delivery of mTOR inhibitors and incorporate various solvents, gelling agents, and antioxidants. His innovative approach aims to provide effective treatment options for skin disorders by utilizing these advanced formulations.

Career Highlights

Wesley Kaupinen holds a vital position at Palvella Therapeutics, Inc., where he contributes his expertise in developing therapeutic solutions. His work is at the intersection of science and technology, driving forward the research on mTOR inhibitors that can revolutionize treatment methods.

Collaborations

Throughout his career, Kaupinen has collaborated with notable professionals in his field, including Braham Shroot and Simon David Betson. These partnerships highlight the collaborative nature of innovation and the importance of teamwork in bringing new ideas to fruition.

Conclusion

Wesley Harton Kaupinen represents the spirit of innovation in the biotechnology sector. With his impressive portfolio of patents and a commitment to advancing treatment options for skin disorders, Kaupinen continues to pave the way for future advancements in the field. His work at Palvella Therapeutics and collaboration with esteemed colleagues showcase the impactful contributions he is making to enhance medical therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…